{"url":"https://lda.senate.gov/api/v1/filings/2b6081ca-c8a4-482f-8297-e59c06b94953/","filing_uuid":"2b6081ca-c8a4-482f-8297-e59c06b94953","filing_type":"Q4","filing_type_display":"4th Quarter - Report","filing_year":2014,"filing_period":"fourth_quarter","filing_period_display":"4th Quarter (Oct 1 - Dec 31)","filing_document_url":"https://lda.senate.gov/filings/public/filing/2b6081ca-c8a4-482f-8297-e59c06b94953/print/","filing_document_content_type":"text/html","income":"30000.00","expenses":null,"expenses_method":null,"expenses_method_display":null,"posted_by_name":"Katina Pierce","dt_posted":"2015-01-16T16:03:16.247000-05:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"600 Maryland Avenue, SW","registrant_address_2":"SUITE 835W","registrant_different_address":false,"registrant_city":"WASHINGTON","registrant_state":"DC","registrant_zip":"20024","registrant":{"id":8511,"url":"https://lda.senate.gov/api/v1/registrants/8511/","house_registrant_id":31321,"name":"CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.","description":"Consultant firm","address_1":"600 Maryland Avenue SW","address_2":"Suite 220E","address_3":null,"address_4":null,"city":"Washington","state":"DC","state_display":"District of Columbia","zip":"20024","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"KATINA PIERCE","contact_telephone":"+1 202-484-1100","dt_updated":"2026-07-07T12:11:18.019485-04:00"},"client":{"id":112794,"url":"https://lda.senate.gov/api/v1/clients/112794/","client_id":1004672,"name":"ONYX PHARMACEUTICALS","general_description":"Biopharmaceutical company that manufactures drugs for cancer.","client_government_entity":false,"client_self_select":false,"state":"DC","state_display":"District of Columbia","country":"US","country_display":"United States of America","ppb_state":null,"ppb_state_display":null,"ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2010-12-15"},"lobbying_activities":[{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"Innovation in biotechnology; health disparities; environmental exposures as a risk factor for cancer.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":56984,"prefix":"ms","prefix_display":"MS.","first_name":"JENNIFER","nickname":null,"middle_name":"RACHEL","last_name":"LEIB","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]}